CL2012001400A1 - Método para detectar una infección activa por mycobacterium tuberculosis que comprende obtener un conjunto de datos de la expresión genética de pacientes de un paciente sospechado de una infección latente/asintomática por mycobacterium tuberculosis. - Google Patents
Método para detectar una infección activa por mycobacterium tuberculosis que comprende obtener un conjunto de datos de la expresión genética de pacientes de un paciente sospechado de una infección latente/asintomática por mycobacterium tuberculosis.Info
- Publication number
- CL2012001400A1 CL2012001400A1 CL2012001400A CL2012001400A CL2012001400A1 CL 2012001400 A1 CL2012001400 A1 CL 2012001400A1 CL 2012001400 A CL2012001400 A CL 2012001400A CL 2012001400 A CL2012001400 A CL 2012001400A CL 2012001400 A1 CL2012001400 A1 CL 2012001400A1
- Authority
- CL
- Chile
- Prior art keywords
- mycobacterium tuberculosis
- infection
- latent
- patients
- detecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/628,148 US20110129817A1 (en) | 2009-11-30 | 2009-11-30 | Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012001400A1 true CL2012001400A1 (es) | 2014-05-09 |
Family
ID=44067161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012001400A CL2012001400A1 (es) | 2009-11-30 | 2012-05-30 | Método para detectar una infección activa por mycobacterium tuberculosis que comprende obtener un conjunto de datos de la expresión genética de pacientes de un paciente sospechado de una infección latente/asintomática por mycobacterium tuberculosis. |
Country Status (19)
Country | Link |
---|---|
US (2) | US20110129817A1 (es) |
EP (1) | EP2519652A4 (es) |
JP (1) | JP2013511981A (es) |
KR (2) | KR20120107979A (es) |
CN (1) | CN102844444A (es) |
AP (1) | AP2012006346A0 (es) |
AR (1) | AR080570A1 (es) |
AU (1) | AU2010325179B2 (es) |
BR (1) | BR112012013029A2 (es) |
CA (1) | CA2782211A1 (es) |
CL (1) | CL2012001400A1 (es) |
EA (1) | EA201270650A1 (es) |
IL (1) | IL220016A0 (es) |
MX (1) | MX2012006031A (es) |
PE (1) | PE20121690A1 (es) |
SG (1) | SG10201407855WA (es) |
TW (1) | TW201131032A (es) |
WO (1) | WO2011066008A2 (es) |
ZA (1) | ZA201204806B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2524966A1 (en) * | 2011-05-18 | 2012-11-21 | Rheinische Friedrich-Wilhelms-Universität Bonn | Molecular analysis of tuberculosis |
TWI458978B (zh) * | 2011-12-27 | 2014-11-01 | Chengchung Chou | 判別開放性或潛伏性結核菌感染之方法 |
WO2013138497A1 (en) * | 2012-03-13 | 2013-09-19 | Baylor Research Institute | Early detection of tuberculosis treatment response |
CA2867481A1 (en) | 2012-04-13 | 2013-10-17 | Somalogic, Inc. | Tuberculosis biomarkers and uses thereof |
GB201211158D0 (en) * | 2012-06-22 | 2012-08-08 | Univ Nottingham Trent | Biomarkers and uses thereof |
EP2914740B1 (en) * | 2012-10-30 | 2017-09-13 | Imperial Innovations Ltd | Method of detecting active tuberculosis in children in the presence of a co-morbidity |
US20150315643A1 (en) * | 2012-12-13 | 2015-11-05 | Baylor Research Institute | Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis |
WO2014133855A1 (en) * | 2013-02-28 | 2014-09-04 | Caprion Proteomics Inc. | Tuberculosis biomarkers and uses thereof |
GB201315748D0 (en) | 2013-09-04 | 2013-10-16 | Imp Innovations Ltd | Biological methods and materials for use therein |
WO2015048098A1 (en) | 2013-09-24 | 2015-04-02 | Washington University | Diagnostic methods for infectious disease using endogenous gene expression |
WO2015159239A1 (en) * | 2014-04-15 | 2015-10-22 | Stellenbosch University | A method for diagnosing tuberculous meningitis |
CN103954755B (zh) * | 2014-04-30 | 2017-04-05 | 广东省结核病控制中心 | 一种结核分枝杆菌潜伏感染的诊断试剂盒 |
WO2015171552A2 (en) | 2014-05-05 | 2015-11-12 | Emory University | Methods of diagnosing and treating tuberculosis |
CA3001134A1 (en) * | 2015-10-14 | 2017-04-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for diagnosis of tuberculosis |
GB201519872D0 (en) * | 2015-11-11 | 2015-12-23 | Univ Cape Town And Ct For Infectious Disease Res | Biomarkers for prospective determination of risk for development of active tuberculosis |
GB2547034A (en) * | 2016-02-05 | 2017-08-09 | Imp Innovations Ltd | Biological methods and materials for use therein |
KR101888101B1 (ko) * | 2016-09-19 | 2018-08-14 | 충남대학교산학협력단 | Scotin 단백질의 과발현에 의하여 결핵균 생존 및 증식을 억제하는 방법 |
JP6306124B2 (ja) * | 2016-11-01 | 2018-04-04 | 国立大学法人高知大学 | 結核検査用バイオマーカー |
CN107653313B (zh) * | 2017-09-12 | 2021-07-09 | 首都医科大学附属北京胸科医院 | Retn和klk1在作为结核病检测标志物中的应用 |
US11443433B2 (en) * | 2018-02-10 | 2022-09-13 | The Trustees Of The University Of Pennsylvania | Quantification and staging of body-wide tissue composition and of abnormal states on medical images via automatic anatomy recognition |
GB201804019D0 (en) | 2018-03-13 | 2018-04-25 | Univ Cape Town | Method for predicting progression to active tuberculosis disease |
US11036779B2 (en) * | 2018-04-23 | 2021-06-15 | Verso Biosciences, Inc. | Data analytics systems and methods |
CN108828235A (zh) * | 2018-08-23 | 2018-11-16 | 中国人民解放军第三〇九医院 | Pglyrp1蛋白作为标志物在诊断活动性结核病中的应用 |
CN109061191B (zh) * | 2018-08-23 | 2021-08-24 | 中国人民解放军第三〇九医院 | S100p蛋白作为标志物在诊断活动性结核病中的应用 |
CN110286231A (zh) * | 2019-06-19 | 2019-09-27 | 中国人民解放军总医院第八医学中心 | 用于检测cd160蛋白的物质在制备用于诊断活动性结核病的产品中的应用 |
CN111304313A (zh) * | 2019-12-13 | 2020-06-19 | 南方医科大学 | 一种检测fpr1基因表达水平的试剂的应用 |
EP3868894A1 (en) * | 2020-02-21 | 2021-08-25 | Forschungszentrum Borstel, Leibniz Lungenzentrum | Method for diagnosis and treatment monitoring and individual therapy end decision in tuberculosis infection |
CN116994646B (zh) * | 2023-08-01 | 2024-06-11 | 东莞市滨海湾中心医院(东莞市太平人民医院、东莞市第五人民医院) | 一种菌阳活动性肺结核风险评估模型的构建方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627198B2 (en) * | 1997-03-13 | 2003-09-30 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis antigens and their uses |
US6713257B2 (en) * | 2000-08-25 | 2004-03-30 | Rosetta Inpharmatics Llc | Gene discovery using microarrays |
EP1425412A2 (en) * | 2000-11-28 | 2004-06-09 | University Of Cincinnati | Blood assessment of injury |
EP2196473A1 (en) * | 2001-07-04 | 2010-06-16 | Health Protection Agency | Mycobacterial antigens expressed during latency |
AU2003241055A1 (en) * | 2002-06-20 | 2004-01-06 | Glaxo Group Limited | Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis |
AU2009262112A1 (en) * | 2008-06-25 | 2009-12-30 | Baylor Research Institute | Blood transcriptional signature of mycobacterium tuberculosis infection |
-
2009
- 2009-11-30 US US12/628,148 patent/US20110129817A1/en not_active Abandoned
-
2010
- 2010-08-19 KR KR1020127017108A patent/KR20120107979A/ko active Application Filing
- 2010-08-19 EP EP10833713.0A patent/EP2519652A4/en not_active Withdrawn
- 2010-08-19 CA CA2782211A patent/CA2782211A1/en not_active Abandoned
- 2010-08-19 CN CN2010800627107A patent/CN102844444A/zh active Pending
- 2010-08-19 EA EA201270650A patent/EA201270650A1/ru unknown
- 2010-08-19 KR KR1020147014569A patent/KR20140078768A/ko not_active Application Discontinuation
- 2010-08-19 AU AU2010325179A patent/AU2010325179B2/en not_active Ceased
- 2010-08-19 WO PCT/US2010/046042 patent/WO2011066008A2/en active Application Filing
- 2010-08-19 JP JP2012541071A patent/JP2013511981A/ja not_active Ceased
- 2010-08-19 BR BR112012013029A patent/BR112012013029A2/pt not_active IP Right Cessation
- 2010-08-19 SG SG10201407855WA patent/SG10201407855WA/en unknown
- 2010-08-19 PE PE2012000735A patent/PE20121690A1/es not_active Application Discontinuation
- 2010-08-19 MX MX2012006031A patent/MX2012006031A/es not_active Application Discontinuation
- 2010-08-19 AP AP2012006346A patent/AP2012006346A0/xx unknown
- 2010-11-30 AR ARP100104425A patent/AR080570A1/es unknown
- 2010-11-30 TW TW099141689A patent/TW201131032A/zh unknown
-
2012
- 2012-05-24 IL IL220016A patent/IL220016A0/en unknown
- 2012-05-30 CL CL2012001400A patent/CL2012001400A1/es unknown
- 2012-06-27 ZA ZA2012/04806A patent/ZA201204806B/en unknown
-
2013
- 2013-09-11 US US14/024,142 patent/US20140080732A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2013511981A (ja) | 2013-04-11 |
KR20120107979A (ko) | 2012-10-04 |
AR080570A1 (es) | 2012-04-18 |
EP2519652A4 (en) | 2013-05-01 |
SG10201407855WA (en) | 2015-01-29 |
AP2012006346A0 (en) | 2012-06-30 |
IL220016A0 (en) | 2012-07-31 |
AU2010325179A1 (en) | 2012-07-05 |
EP2519652A2 (en) | 2012-11-07 |
US20140080732A1 (en) | 2014-03-20 |
TW201131032A (en) | 2011-09-16 |
MX2012006031A (es) | 2012-10-03 |
WO2011066008A2 (en) | 2011-06-03 |
WO2011066008A3 (en) | 2011-07-21 |
BR112012013029A2 (pt) | 2016-10-04 |
ZA201204806B (en) | 2013-02-27 |
EA201270650A1 (ru) | 2013-06-28 |
CN102844444A (zh) | 2012-12-26 |
CA2782211A1 (en) | 2011-06-03 |
PE20121690A1 (es) | 2012-12-16 |
AU2010325179B2 (en) | 2015-03-12 |
KR20140078768A (ko) | 2014-06-25 |
US20110129817A1 (en) | 2011-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2012001400A1 (es) | Método para detectar una infección activa por mycobacterium tuberculosis que comprende obtener un conjunto de datos de la expresión genética de pacientes de un paciente sospechado de una infección latente/asintomática por mycobacterium tuberculosis. | |
WO2011135459A3 (en) | Methods and devices for predicting treatment efficacy | |
PE20110386A1 (es) | Patron de transcripcion sanguinea de la infeccion por mycobacterium tuberculosis | |
BR112013011031A2 (pt) | dispositivo de informação do paciente, sistema de monitoramento de paciente, método para predizer uma variável de resultado do paciente, meio legível por computador e método de predizer uma probabilidade de resultado | |
BRPI0912793A2 (pt) | dispositivo de detecção de anormalidade para um dispositivo de assistência a coração, sistema de dispositivo de assistência a coração, método para detectar uma anormalidade de um dispositivo de assistência a coração, e, programa de detecção de estado anormal de um dispositivo de assitência a coração. | |
WO2012173976A3 (en) | Methods and apparatus for assessing activity of an organ and uses thereof | |
ATE493290T1 (de) | Alcotestgerät | |
BRPI0920253A2 (pt) | dispositivo de agulha cirúrgica, sistema de agulha cirúrgica, e, método para usar um dispositivo de agulha cirúrgica. | |
BRPI0720349A2 (pt) | Método para operar um instrumento acoplado com um sistema microcirúrgico. | |
BR112013003193A2 (pt) | método de gerenciamento de atualizações, meio não transitório de registro legível por computador possuindo gravado por sobre ele um programa para executar um método de gerenciamento de atualizações, e equipamento de gerenciamento de atualizações e equipamento de ferenciamento de atualizações. | |
WO2011107482A3 (en) | Method of diagnostic of obesity | |
EP2579779A4 (en) | Integrated, hand-held apparatus and associated method for acquiring diagnostic and prognostic information from a patient at the bedside or at some other patient location | |
CY1122360T1 (el) | Μεθοδος για τη διαγνωση της νοσου niemann-pick | |
BR112013019585A2 (pt) | método e dispositivo para adquirir imagens de ultrassom de alta resolução de um meio, programa de computador, e, meio de armazenamento legível por computador. | |
BRPI0812771A2 (pt) | Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção . | |
BR112013004062A2 (pt) | dispositivo de navegação para determinação da localização do dispositivo, método para determinação da localização de um dispositivo e meio legível por computador | |
NL2003181A1 (nl) | A source module of an EUV lithographic apparatus, a lithographic apparatus, and a method for manufacturing a device. | |
BRPI0910794A2 (pt) | método para atualizar uma imagem de cliente fino, sistema de computador e método para atualizar um sistema operacional de clente fino | |
CL2011002260A1 (es) | Metodo o sistema para el seguimiento del tratamiento de un individuo que comprende determinar si una muestra de dicho individuo comprende un biomarcador. | |
WO2012068040A3 (en) | Detection of vestibular disorders based on vestibular noise | |
BRPI0822889A2 (pt) | Dispositivo anti-retorno, e, método para testar a integridade operacional de um dispositivo anti-retorno. | |
FR2937339B1 (fr) | Procede de detection de la maladie atheromateuse. | |
BR112012006114A2 (pt) | aparelho para o obtenção de informações diagnósticas, método para a obtenção de informações dianósticas e programas de computador | |
BRPI1013677A2 (pt) | método para detectar inflamação ou infecção, e, usos de um 13c-piruvato hiperpolarizado, e de um meio de formação de imagem. | |
BR112015002567A2 (pt) | sistema de imagens para a análise das vias aéreas de um paciente, método para a análise das vias aéreas de um paciente, e fantasma de hardware. |